Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Perlin

Showing results (151-160 of 284) with videos related to

Pageof 29
Sort By:
Antimicrobial Agents and Chemotherapy|January 20, 2021
Therapeutic Potential of Fosmanogepix (APX001) for Intra-abdominal Candidiasis: from Lesion Penetration to Efficacy in a Mouse ModelAnnie Lee, Ning Wang, Claire L Carter, et al.
Journal of Clinical Microbiology|May 1, 2009
Rapid real-time nucleic Acid sequence-based amplification-molecular beacon platform to detect fungal and bacterial bloodstream infectionsYanan Zhao, Steven Park, Barry N Kreiswirth, et al.
International Journal of Antimicrobial Agents|October 13, 2006
Multi-azole resistance in Aspergillus fumigatusSusan J Howard, Ian Webster, Caroline B Moore, et al.
Antimicrobial Agents and Chemotherapy|February 26, 2014
Doripenem, gentamicin, and colistin, alone and in combinations, against gentamicin-susceptible, KPC-producing Klebsiella pneumoniae strains with various ompK36 genotypesCornelius J Clancy, Binghua Hao, Ryan K Shields, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2011
Are we ready for novel detection methods to treat respiratory pathogens in hospital-acquired pneumonia?Andrea Endimiani, Kristine M Hujer, Andrea M Hujer, et al.
The Journal of Clinical Investigation|December 6, 2021
Randomized, double-blind, controlled trial of human anti-LIGHT monoclonal antibody in COVID-19 acute respiratory distress syndromeDavid S Perlin, Garry A Neil, Colleen Anderson, et al.
Journal of Fungi (Basel, Switzerland)|August 23, 2020
The Quiet and Underappreciated Rise of Drug-Resistant Invasive Fungal PathogensAmir Arastehfar, Cornelia Lass-Flörl, Rocio Garcia-Rubio, et al.
Antimicrobial Agents and Chemotherapy|March 29, 2018
Correction for Yang et al., "Tolerance to Caspofungin in Candida albicans Is Associated with at Least Three Distinctive Mechanisms That Govern Expression of <i>FKS</i> Genes and Cell Wall Remodeling"Feng Yang, Lulu Zhang, Hironao Wakabayashi, et al.
The Journal of Trauma and Acute Care Surgery|September 26, 2015
Carbohydrate-derived fulvic acid is a highly promising topical agent to enhance healing of wounds infected with drug-resistant pathogensYanan Zhao, Padmaja Paderu, Guillaume Delmas, et al.
Antimicrobial Agents and Chemotherapy|February 23, 2017
Tolerance to Caspofungin in Candida albicans Is Associated with at Least Three Distinctive Mechanisms That Govern Expression of <i>FKS</i> Genes and Cell Wall RemodelingFeng Yang, Lulu Zhang, Hironao Wakabayashi, et al.
Pageof 29

Showing results (151-160 of 284) with videos related to

Sort By:
Pageof 29
Antimicrobial Agents and Chemotherapy|January 20, 2021
Therapeutic Potential of Fosmanogepix (APX001) for Intra-abdominal Candidiasis: from Lesion Penetration to Efficacy in a Mouse ModelAnnie Lee, Ning Wang, Claire L Carter, et al.
Journal of Clinical Microbiology|May 1, 2009
Rapid real-time nucleic Acid sequence-based amplification-molecular beacon platform to detect fungal and bacterial bloodstream infectionsYanan Zhao, Steven Park, Barry N Kreiswirth, et al.
International Journal of Antimicrobial Agents|October 13, 2006
Multi-azole resistance in Aspergillus fumigatusSusan J Howard, Ian Webster, Caroline B Moore, et al.
Antimicrobial Agents and Chemotherapy|February 26, 2014
Doripenem, gentamicin, and colistin, alone and in combinations, against gentamicin-susceptible, KPC-producing Klebsiella pneumoniae strains with various ompK36 genotypesCornelius J Clancy, Binghua Hao, Ryan K Shields, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2011
Are we ready for novel detection methods to treat respiratory pathogens in hospital-acquired pneumonia?Andrea Endimiani, Kristine M Hujer, Andrea M Hujer, et al.
The Journal of Clinical Investigation|December 6, 2021
Randomized, double-blind, controlled trial of human anti-LIGHT monoclonal antibody in COVID-19 acute respiratory distress syndromeDavid S Perlin, Garry A Neil, Colleen Anderson, et al.
Journal of Fungi (Basel, Switzerland)|August 23, 2020
The Quiet and Underappreciated Rise of Drug-Resistant Invasive Fungal PathogensAmir Arastehfar, Cornelia Lass-Flörl, Rocio Garcia-Rubio, et al.
Antimicrobial Agents and Chemotherapy|March 29, 2018
Correction for Yang et al., "Tolerance to Caspofungin in Candida albicans Is Associated with at Least Three Distinctive Mechanisms That Govern Expression of <i>FKS</i> Genes and Cell Wall Remodeling"Feng Yang, Lulu Zhang, Hironao Wakabayashi, et al.
The Journal of Trauma and Acute Care Surgery|September 26, 2015
Carbohydrate-derived fulvic acid is a highly promising topical agent to enhance healing of wounds infected with drug-resistant pathogensYanan Zhao, Padmaja Paderu, Guillaume Delmas, et al.
Antimicrobial Agents and Chemotherapy|February 23, 2017
Tolerance to Caspofungin in Candida albicans Is Associated with at Least Three Distinctive Mechanisms That Govern Expression of <i>FKS</i> Genes and Cell Wall RemodelingFeng Yang, Lulu Zhang, Hironao Wakabayashi, et al.
Pageof 29